These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

55 related items for PubMed ID: 17210249

  • 1. 1alpha,25-Dihydroxyvitamin D3 enhances proliferation of rat prostate cancer cells in the presence of living bone.
    Herring PA, Ingels J, Palmieri G, Hasty KA.
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):737-41. PubMed ID: 17210249
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of C-2-substituted 19-nor-1alpha,25-dihydroxyvitamin D3 analogs as therapeutic agents for prostate cancer.
    Chen TC, Persons KS, Zheng S, Mathieu J, Holick MF, Lee YF, Bao B, Arai MA, Kittaka A.
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):717-20. PubMed ID: 17207993
    [Abstract] [Full Text] [Related]

  • 3. Substitution at carbon 2 of 19-nor-1α,25-dihydroxyvitamin D3 with 3-hydroxypropyl group generates an analogue with enhanced chemotherapeutic potency in PC-3 prostate cancer cells.
    Iglesias-Gato D, Zheng S, Flanagan JN, Jiang L, Kittaka A, Sakaki T, Yamamoto K, Itoh T, Lebrasseur NK, Norstedt G, Chen TC.
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):269-75. PubMed ID: 21911059
    [Abstract] [Full Text] [Related]

  • 4. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC, Schwartz GG, Burnstein KL, Lokeshwar BL, Holick MF.
    Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
    [Abstract] [Full Text] [Related]

  • 5. 1alpha,25-Dihydroxyvitamin D3-3beta-(2)-bromoacetate, an affinity labeling derivative of 1alpha,25-dihydroxyvitamin D3 displays strong antiproliferative and cytotoxic behavior in prostate cancer cells.
    Swamy N, Persons KS, Chen TC, Ray R.
    J Cell Biochem; 2003 Aug 01; 89(5):909-16. PubMed ID: 12874825
    [Abstract] [Full Text] [Related]

  • 6. Autocrine/paracrine action of vitamin D on FGF23 expression in cultured rat osteoblasts.
    Tang WJ, Wang LF, Xu XY, Zhou Y, Jin WF, Wang HF, Gao J.
    Calcif Tissue Int; 2010 May 01; 86(5):404-10. PubMed ID: 20354682
    [Abstract] [Full Text] [Related]

  • 7. Growth inhibition and differentiation in human prostate carcinoma cells induced by the vitamin D analog 1alpha,24-dihydroxyvitamin D2.
    Bauer JA, Thompson TA, Church DR, Ariazi EA, Wilding G.
    Prostate; 2003 May 15; 55(3):159-67. PubMed ID: 12692781
    [Abstract] [Full Text] [Related]

  • 8. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
    Aparna R, Subhashini J, Roy KR, Reddy GS, Robinson M, Uskokovic MR, Venkateswara Reddy G, Reddanna P.
    J Cell Biochem; 2008 Aug 01; 104(5):1832-42. PubMed ID: 18348265
    [Abstract] [Full Text] [Related]

  • 9. Induction of apoptosis and inhibition of prostate and breast cancer growth by BGP-15, a new calcipotriene-derived vitamin D3 analog.
    Berkovich L, Ben-Shabat S, Sintov AC.
    Anticancer Drugs; 2010 Jul 01; 21(6):609-18. PubMed ID: 20335794
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
    Lokeshwar BL, Schwartz GG, Selzer MG, Burnstein KL, Zhuang SH, Block NL, Binderup L.
    Cancer Epidemiol Biomarkers Prev; 1999 Mar 01; 8(3):241-8. PubMed ID: 10090302
    [Abstract] [Full Text] [Related]

  • 11. Human prostate cancer cells: inhibition of proliferation by vitamin D analogs.
    Schwartz GG, Oeler TA, Uskoković MR, Bahnson RR.
    Anticancer Res; 1994 Mar 01; 14(3A):1077-81. PubMed ID: 8074453
    [Abstract] [Full Text] [Related]

  • 12. Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells.
    Khanim FL, Gommersall LM, Wood VH, Smith KL, Montalvo L, O'Neill LP, Xu Y, Peehl DM, Stewart PM, Turner BM, Campbell MJ.
    Oncogene; 2004 Sep 02; 23(40):6712-25. PubMed ID: 15300237
    [Abstract] [Full Text] [Related]

  • 13. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
    Campbell MJ, Gombart AF, Kwok SH, Park S, Koeffler HP.
    Oncogene; 2000 Oct 19; 19(44):5091-7. PubMed ID: 11042697
    [Abstract] [Full Text] [Related]

  • 14. 1Alpha,25dihydroxyvitamin D3 and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines.
    Moffatt KA, Johannes WU, Miller GJ.
    Clin Cancer Res; 1999 Mar 19; 5(3):695-703. PubMed ID: 10100724
    [Abstract] [Full Text] [Related]

  • 15. 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport.
    Kolek OI, Hines ER, Jones MD, LeSueur LK, Lipko MA, Kiela PR, Collins JF, Haussler MR, Ghishan FK.
    Am J Physiol Gastrointest Liver Physiol; 2005 Dec 19; 289(6):G1036-42. PubMed ID: 16020653
    [Abstract] [Full Text] [Related]

  • 16. 1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer.
    Nakagawa K, Kawaura A, Kato S, Takeda E, Okano T.
    Carcinogenesis; 2005 Feb 19; 26(2):429-40. PubMed ID: 15539405
    [Abstract] [Full Text] [Related]

  • 17. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3.
    Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar BL, Holick MF.
    Cancer Epidemiol Biomarkers Prev; 1998 May 19; 7(5):391-5. PubMed ID: 9610788
    [Abstract] [Full Text] [Related]

  • 18. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.
    Barreto AM, Schwartz GG, Woodruff R, Cramer SD.
    Cancer Epidemiol Biomarkers Prev; 2000 Mar 19; 9(3):265-70. PubMed ID: 10750664
    [Abstract] [Full Text] [Related]

  • 19. [The effects of 1alpha,25-dihydroxyvitamin D3 in regulation matrix metalloproteinase and tissue metalloproteinase inhibitors in human osteoblasts].
    Guo LJ, Luo XH, Xie H, Zhou HD, Liao EY.
    Zhonghua Nei Ke Za Zhi; 2005 Feb 19; 44(2):125-8. PubMed ID: 15840226
    [Abstract] [Full Text] [Related]

  • 20. 1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells.
    Schwartz GG, Wang MH, Zang M, Singh RK, Siegal GP.
    Cancer Epidemiol Biomarkers Prev; 1997 Sep 19; 6(9):727-32. PubMed ID: 9298581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.